A web-based, user-centered decision aid to support parental choices in myopia control: A development and usability study

一款基于网络、以用户为中心的决策辅助工具,旨在帮助家长做出近视控制方面的选择:一项开发和可用性研究

阅读:3

Abstract

BACKGROUND: Childhood myopia, intensified by rapid technological advancements, is an escalating public health issue. Shared decision-making (SDM) facilitates collaborative treatment engagement and adherence, contributing to the mitigation of myopia progression. OBJECTIVE: This study developed and evaluated a web-based decision aid aimed at assisting parents in making informed, value-aligned decisions. METHODS: Following the International Patient Decision Aid Standards framework, we conducted a two-phase process: development (scoping, stakeholder engagement, and content planning) and testing (prototype creation and alpha and beta testing with external users) to develop the Childhood Myopia Shared Decision-Making Aid (CMSDM) to support informed and value-congruent treatment decisions. The study involved 55 parents, 12 ophthalmologists, 3 school nurses, 2 health education teachers, and 20 optometrists. RESULTS: CMSDM comprises two decision aids (myopia treatment and optical correction) with six components: (1) Introduction-stating the purpose of the tool; (2) Comparison-outlining treatment options with pros and cons; (3) Consideration-prompting value reflection; (4) Understanding-clarifying key points; (5) Decision-guiding informed choice; and (6) Submission-sharing the decision with the ophthalmologist. A review from five experts provided the aid with a content validity index of 0.85, demonstrating consensus on content relevance. Users reported a mean System Usability Scale score of 85, indicating excellent usability. The use of CMSDM was associated with improved parental knowledge (t = 2.31, p < 0.01; Cohen's d = 0.60) and reduced decisional regret (t = 2.01, p < 0.05; Cohen's d = 0.52) in preliminary testing. CONCLUSIONS: CMSDM, the first SDM aid for childhood myopia, supports informed parental choice. Its effectiveness should be further examined in randomized controlled trials.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。